Table 1.
Formulation | Particle size (nm) | PDI | Zeta potential (mV) |
---|---|---|---|
NPs | 104.5±4.0 | 0.141±0.016 | −24.1±1.3 |
TNPs | 106.6±6.2 | 0.157±0.015 | −22.5±1.9 |
DiR NPs | 109.9±5.4 | 0.166±0.027 | −23.4±1.1 |
DiR TNPs | 113.2±4.8 | 0.167±0.010 | −22.9±1.3 |
Coumarin 6 NPs | 108.2±3.3 | 0.169±0.017 | −23.9±1.8 |
Coumarin 6 TNPs | 110.1±3.7 | 0.170±0.020 | −23.3±1.9 |
PTX NPs | 112.3±5.7 | 0.172±0.006 | −21.9±2.5 |
PTX TNPs | 115.5±5.9 | 0.201±0.011 | −20.4±2.1 |
Abbreviations: PDI, polydispersity index; CREKA, cysteine–arginine–glutamic acid–lysine–alanine; TNPs, CREKA-conjugated NPs; DiR, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine iodide; PTX, paclitaxel.